NEWS RELEASE For Information:
FOR IMMEDIATE RELEASE Cari Reisinger
Seniors Risk Health to Avoid High Prescription Costs
Drug industry critics expose how Big Pharma takes advantage of seniors
LOS ANGELES, CA – As prescription drug costs soar to more than $1,800 annually for seniors, many elderly Americans are risking their health by not having their prescriptions filled--this at a time when the pharmaceutical industry’s marketing budgets and annual profits are bigger than ever.
and pharmaceutical industry critics expose how Big Pharma’s
billion dollar marketing tactics drive up prescription costs in the timely
documentary Money Talks: Profits Before Patient Safety. (Now available
on DVD.) The film's featured interviewees include Harvard’s Dr. John
Abramson, author of Overdo$ed America, Columbia University’s Dr. Bob
Goodman, founder of the ‘No Free Lunch’ program, Dr. Jerome Hoffman of
Money Talks: Profits Before
Patient Safety is
filmmaker Kathleen Slattery-Moschkau’s second film
about issues involving the pharmaceutical industry. Her debut feature, Side Effects, was a fictional treatment
of her decade working as a sales rep for two of the nation’s top drug
companies. Because of the questions posed by Side Effects audiences, Slattery-Moschkau felt compelled to present
a more comprehensive, academic approach to the topic of pharmaceutical
marketing tactics for her second film.
“Side Effects generated such an outstanding dialogue on the issues of drug promotion and ethics that we felt compelled to go to the experts,” said Slattery-Moschkau. “Money Talks is straight-shooting information every consumer should have.”
In Money Talks, Alex Sugerman-Brozan, Director of Prescription Access Litigation, shares shocking statistics about the pharmaceutical industry’s formidable marketing force. He cites that there are over 80,000 pharmaceutical sales reps employed in the
Dr. John Abramson, author of Overdo$ed America, exposes how once-trusted entities like the Food and Drug Administration and The New England Journal of Medicine are no longer sources of unbiased information on prescription drugs due to their
financial ties to the pharmaceutical industry.
For more information on the issues raised in Money Talks, visit www.moneytalksthemovie.com. To arrange an interview with filmmaker Kathleen Slattery-Moschkau, contact Cari Reisinger of Hummingbird Pictures at (209) 736-6769 or firstname.lastname@example.org.